Does ROSUVASTATIN Cause Benign prostatic hyperplasia? 148 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 148 reports of Benign prostatic hyperplasia have been filed in association with ROSUVASTATIN (Rosuvastatin Calcium). This represents 0.4% of all adverse event reports for ROSUVASTATIN.
148
Reports of Benign prostatic hyperplasia with ROSUVASTATIN
0.4%
of all ROSUVASTATIN reports
29
Deaths
113
Hospitalizations
How Dangerous Is Benign prostatic hyperplasia From ROSUVASTATIN?
Of the 148 reports, 29 (19.6%) resulted in death, 113 (76.4%) required hospitalization, and 17 (11.5%) were considered life-threatening.
Is Benign prostatic hyperplasia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN. However, 148 reports have been filed with the FAERS database.
What Other Side Effects Does ROSUVASTATIN Cause?
Myalgia (3,958)
Dyspnoea (2,832)
Pain (2,758)
Drug ineffective (2,347)
Fatigue (2,208)
Rhabdomyolysis (2,173)
Arthralgia (1,879)
Asthma (1,843)
Muscle spasms (1,843)
Pain in extremity (1,686)
What Other Drugs Cause Benign prostatic hyperplasia?
TADALAFIL (596)
TAMSULOSIN (304)
FINASTERIDE (266)
PANTOPRAZOLE (261)
PREDNISONE (257)
ALBUTEROL (254)
ASPIRIN (243)
TIOTROPIUM (235)
RAMIPRIL (193)
AMLODIPINE (179)
Which ROSUVASTATIN Alternatives Have Lower Benign prostatic hyperplasia Risk?
ROSUVASTATIN vs ROSUVASTATIN\ROSUVASTATIN
ROSUVASTATIN vs ROTIGOTINE
ROSUVASTATIN vs ROXADUSTAT
ROSUVASTATIN vs ROXICODONE
ROSUVASTATIN vs ROXITHROMYCIN